phase readout
saveNCT06931340: Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
RECRUITINGupdated 2h ago
community read0 votes
Sponsor: Alliance for Clinical Trials in Oncology. Phase: PHASE3. Conditions: Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8
view source ↗
comments(0)
5-min edit window · permanent after that